chrisvoncsefalvay/vaers-outcomes huggingface dataset:
my right arm is sore; pressure in my chest; tingly feeling in my head; felt a little bit funny/ feel a little bit off; heat in my stomach/ my stomach was so hot; Weird side effects; very tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (pressure in my chest), PARAESTHESIA (tingly feeling in my head), FEELING ABNORMAL (felt a little bit funny/ feel a little bit off), ABDOMINAL DISCOMFORT (heat in my stomach/ my stomach was so hot) and VACCINATION COMPLICATION (Weird side effects) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Sep-2021, the patient experienced CHEST DISCOMFORT (pressure in my chest), PARAESTHESIA (tingly feeling in my head), FEELING ABNORMAL (felt a little bit funny/ feel a little bit off), ABDOMINAL DISCOMFORT (heat in my stomach/ my stomach was so hot), VACCINATION COMPLICATION (Weird side effects) and FATIGUE (very tired). On an unknown date, the patient experienced MYALGIA (my right arm is sore). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CHEST DISCOMFORT (pressure in my chest), PARAESTHESIA (tingly feeling in my head), FEELING ABNORMAL (felt a little bit funny/ feel a little bit off), ABDOMINAL DISCOMFORT (heat in my stomach/ my stomach was so hot), VACCINATION COMPLICATION (Weird side effects), FATIGUE (very tired) and MYALGIA (my right arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication includes citrocine two a day (Regularly but not everyday)
Dizziness starting around 4am on 12/31/20. Progressed into body aches, chills, severe headache and fever of 101.9 degrees over the course of the morning. I sweat through 3 layers of clothing during the night. Now on 1/1/21 at 4pm I am still achey, especially in my legs. I feel weak and my temperature has come down to 100.4.
15 min after the shot: dizziness, swollen face , hard to swallow.   45 min after shot: nausea, very week; can't walk alone, sinus stuffiness, excess laughing, lethargy; unclear head
mom reported pt leg swollen 5" area;mom brought child to hlth dept;large hive-like area 7 1/2" x 5"; red/very warm to touch; c/o h/a;pt scratching leg frequently because of sever itching;area on RAT (MMR) size;half dollar-red swollen warm;
having an allergic reaction to the first moderna covid shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (having an allergic reaction to the first moderna covid shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (having an allergic reaction to the first moderna covid shot). At the time of the report, ALLERGY TO VACCINE (having an allergic reaction to the first moderna covid shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Per patient she received her flu shot on Thursday 9/2/21 in the morning and then on Friday 9/3/21 she noticed a red slightly itchy area about 2 and 1/2 to 3 inches below the injection site. She described that it looks hive like and it a 7inch by 3in oval shape that goes side to side across her arm. She took Zyrtec and that did help. Patient will follow up with md regarding injection site reaction.
Chills, diarrhea, vomiting, body ache, swelling, redness, itching, fatigue, dizziness, loss of appetite
Instant headache that subsided quickly, sore arm at injection site for 48 hours, rash covering torso and arms and neck that is very itchy and sore
Sore arm at injection site starting on Day 1. Splotchy, non-itchy rash on torso starting on Day 2.
Patient developed an allergic reaction several hours after recieving the flu immunization. Patient reported to the ER and was treated and released.
fully vaccinated (pfizer, 2/3/21, 3/2/21); onset of symptoms 7/31/21
extreme temperature drop; extreme fatigue; headache; joint pain; right side of face and ear painful; Next day - drenched, trouble controlling temperature, headache & joint pain and nausea
acute hypoxic respiratory failure, aspiration pneumonia, severe hypernatremia, AKI. Died right after admission due to worsening hypoxia and developed pulseless Vtach arrest.
From telephone contact received at manufacturer on 6/6/02, it was reported by a health care professional that a 4 year old female received Tripedia vaccine. Patient developed a large local redness and swelling (7cmx7cm) at injection site. Two other patients with same reaction from Lot U0544AA. Follow up on 10/7/02: the reporter was contacted on 10/7/02 to request additional info about other two patients with reactions to Tripedia. However, the reporter was not able to provide pt identifiers or other specific info regarding these events.
Noted change of consciousness in evening following vaccination.  She had a tonic gaze to the right when EMS 1st arrived at the scene.  She was not having any overt epileptic activity. She is normally very debilitated and moderately demented but conversational and jovial according to the daughter.  She is normally able to be fed, taken to the toilet, and has no trouble with day-to-day living.  She was brought to this hospital day after vaccination.  She was alert at the time of the vaccination.  She had COVID in August of this last year.  In ED, she was given a very small dose of Ativan.  She had immediate effect from this with resolution of the tonic gaze, developed a voluntary gaze and had minimal but clear-cut purposeful conversation.  She was also able to move her extremities after the Ativan.  Prior to that she was fairly rigid in her extremities.  She did not have any obvious seizure activity however.  She was transferred to another hospital for higher level of care and continued management.
Pt developed tactile fever and vomiting 15 minutes after vaccine was administered. She was tired for the rest of the day, briefly stumbled to one side when carried out of the shower and placed on the floor, woke up and vomited and was febrile about 12 hours after vaccine given. Seen in office the next day with normal exam.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2 NOS), on 01Nov2022 at 14:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 50 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Tested positive again starting four days after last Dose. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: No other medication in 2 weeks, No Known allergies, Other medical history were none. The patient received Paxlovid Treatment start date: 17Jan2023, stop date: 21Jan2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt recvd vax & exp inj site rxn right arm of redness,raised bump,soreness & inflammation.
Pt developed a fever, (R) shoulder pain, & pain with deep breathing a few hours after getting flu vaccine.
It was reported post vaccine pt developed 5-6cm inflamed raised area of erythema.
very sore arm, followed by on and off fever and chills. dizzy. fever of 102. Nausea/vomitting on day 3. still not feeling completely well on day 5.
pt exp light headedness, drowsiness, dry mouth & achy arm; layed down @ place of employment & slept; sx better now but still lingering drowsiness & dry mouth;
This spontaneous report as received from a nurse refers to a 71 year old patient. Medical history and concurrent conditions were not reported. On 24-JAN-2014, the patient was vaccinated with PNEUMOVAX 23 lot #J005067; expiration date: 17-JAN-2015 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored PNEUMOVAX 23 was administered to patient. No adverse effects reported. On 13-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, PNEUMOVAX 23 the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
no adverse events; adult patient received the monovalent Moderna booster dose instead of a bivalent booster; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT PRODUCT FORMULATION ADMINISTERED (adult patient received the monovalent Moderna booster dose instead of a bivalent booster) and NO ADVERSE EVENT (no adverse events) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Oct-2022, the patient experienced INCORRECT PRODUCT FORMULATION ADMINISTERED (adult patient received the monovalent Moderna booster dose instead of a bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse events). At the time of the report, INCORRECT PRODUCT FORMULATION ADMINISTERED (adult patient received the monovalent Moderna booster dose instead of a bivalent booster) and NO ADVERSE EVENT (no adverse events) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse events) to be not related. No further causality assessment was provided for INCORRECT PRODUCT FORMULATION ADMINISTERED (adult patient received the monovalent Moderna booster dose instead of a bivalent booster).    No concomitant information provided No treatment information provided
This spontaneous report was received from a female patient who is over 26 years of age regarding herself. On an unknown date in August 2013, the over 26 year old patient was vaccinated with the first dose of GARDASIL. No side effects have been reported. Additional information has been requested.
Initial report received from the health care professional on 27 Aug 2010: This patient was vaccinated with S-OIV FLUVIRIN (lot number 111799P1) intramuscularly, on 27 Aug 2010. On 27 Aug 2010, during administration, vaccine sprayed out of the needle onto the patient's arm and needle was fully inserted into the patients arm at the time. The outcome of event was not reported. Follow up healthcare professional report received on 06 Sep 2010: It was reported that the patient had medical history of allergy to penicillin and had diabetes. The patient was given 0.5 ml dose of vaccine intramuscularly into the deltoid.
approx 2hr p/vax pt c/o blurred vision, tachycardia, feeling high;taken to local hlth clinic evidence of flat, red, rash on trunk;seen by MD given DPH, cortisone;
The day after receiving the 1st dose of Pfizer vaccine on 5/19,  my heart beat increased to 95-103 beats per minute for the entire 24 hours. I was very tired and could not focus.  I also had muscle aches. Then, on 5/20, my heart beat decreased to 85 without any treatment and I felt much better.
Child reported to school nurse with "blue" and cold hands. R hand blue to wrist, L hand fingertips only. No pain, adequate pulses. To medical provider same afternoon-did not feel the blue/cold was reaction to vaccine. Labs drawn.
Swollen and painful lumps in neck, red and tender to touch . Pain with head movement.   I noticed mild soreness on Mar.22 and it grew progressively worse, with the height of swelling and painfulness occurring on Mar25. On Mar 26, systems were mush less and almost completely gone by Mar 27.
Started with emesis at 7pm on 9/12//per mom -he vomited 5 times before falling asleep at 9pm//slept all night and was ok 9/13 am before school//got to school 8:30am and began vomiting again at 9am x 2 at school and then twice in car on way home from school/sleeping again at 10:30am//no emesis while sleeping or resting/when he becomes active, it starts again//interview w/mom//Mom will call PCP if symptoms persist
Shingles developed roughly 11 days after the second shot. I have been prescribed Valacyclovir and began taking today, so it's early in the process.
I started to get chills at 11PM on 11/18/20 that lasted until 12:30AM and only subsided after I took ibuprofen.  I woke up at 5:45AM on 11/19/20 and have had body aches, felt dizzy and have had off and on chills all day,
Burning chest pain, cough, sore throat, sweats, fever, shortness of breath, sore arm, achey
Information has been received from a 72 year old female with "blood pressure", Oesophageal acid reflux, arthritis, cholesterol high, sulfonamide allergy and allergic to LYRICA who in February or March 2008 was vaccinated with a dose of ZOSTAVAX vaccine (Oka/Merck). Concomitant therapy included ACIPHEM, piroxicam, Pravastatin Na, AVAPRO, ALLEGRA, AMARYL, AMBIEN, CYMBALTA, ROBAXIN and ZYDONE. three weeks ago, on approximately 19-MAY-2008 the patient experienced shingles on her "rear end". It was only about 3 to 4 itchy blisters. The physician prescribed and antiviral medication and the blisters went away however she was still experiencing itching and burning. No product quality complaint was involved. Additional information has been requested.
I had a sore arm and tired for 24 hours after receiving the vaccine. On 12/28/2022, I believe I was exposed to COVID-19 as we had gone out to eat to celebrate a birthday. On 12/30/2022, I started feeling symptoms sore throat, sinus pressure, coughing, light fever and felt out of sorts. On 12/31/2022, I tested positive for COVID-19 with a home test. I contacted my doctor via the patient portal and spoke to a provided. I got a prescription for PAXLOVID and started taking it that day. As of today, I am feeling better, but I continue to feel fatigued.
hives all over body an hour after receiving the vaccine, terrible headache, dizzy, low grade fever and severe flu like symtoms, Took benadryl for two days along with tylenol. called employee health at  where i work in the lab
Pt. presented with tightness in chest feeling shaky and redness on chest, face and arms. Patient vitals taken at 1038, 166/94 81 100% (RA). Patient placed in bed and monitored, at 1115. Pt's vitals 130/84 70 98% (RA). Examined patient, patient stated feeling better.
About 24 hours after getting the vaccine I started to experience facial pain where I have previously had fillers. I noticed pain at the 48-hour mark. I did seek guidance from the place where I had received my fillers of Juvéderm, and they prescribed me prednisone. This lasted for about 5 days and then went away. They advised me to not get any more injections in my face for at least 6 months. I had another round of injections done after the 6 months, in October and nothing happened. I went back and got lip injections, I experienced the same swelling but, in my face, not my lips.
Temperature, dizziness/disorientation, aches, chest pain starting day 14 and continuing at day 18.
Information has been received from a health professional concerning a 15 year old female with a penicillin allergy who on 28-OCT-2008 was vaccinated IM with a third dose of GARDASIL (Lot# 661766/0652X) at 11:45 a.m. into the right deltoid. Concomitant therapy included a third dose of DEPO-PROVERA (manufacturer unknown) IM in the right gluteus in the same day at 11:45 a.m. The health professional reported that the patient received the two vaccines and she had put the needles in sharps and the patient fell straight back to the floor, fainted and hit head. Subsequently the "squad" was called. The patient sought medical attention at SQUAD to hospital. At the time of this report, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Angioedema, SkinRash, Rash, eyelid and lip swelling with facial rash Narrative:  improved with po bendaryl 25 mg po and epinephrine injectable
Patient was found to be in Atrial Fibrillation during routine appt one week after vaccination.  She was asymptomatic with atrial fibrillation. She remains in atrial fibrillation. She is currently being treated with rate control medication, anti-coagulation and awaiting appt with Cardiology for likely cardioversion.
Few welps on right side of face, tingling and numbness in left leg below knee , chest pain
Within minutes of being vaccinated, patient reported her tongue was numb.  BP 140/80.  Benadryl 50mg po administered at 10:40 am.  After 35 minutes, tongue numbness resolved and patient released from clinic.  2/24 telephone call to patient, voicemail left.  2/25 telephone call to patient, no further symptoms and resolved without further treatment.  Will consult with cardiologist regarding next dose.
Patient stated had pain & soreness at injection site this resolved by 4/17/10.  Upon awakening on Sunday noticed that she had a stiff neck left side.  Since then has had on & off sharp pains behind left ear and tenderness with pressure left base skull.  Advised to see physician today.
15 minutes after receiving the vaccine, the patient felt lightheaded and had palpitations. Her chest also got red which she attributed to vasomotor flushing she gets with activity; this was not a rash and was short lived. She was also nauseated and her hands felt slightly numb, she attributed the hand numbness to her Raynaud's disease. She sat in the clinic for another 15 minutes and then went home. On the way home she had chills which she frequently gets when she tries a new medication. The problems lasted one day. She has multiple allergies.
Fatigue, Rash, itching starting on arm of flu shot, progressing to both arms, then over body. Diarrhea, body aches, migraine ill x 9 days. Given CLARITIN - no relief SOLU-MEDROL - minimal relief.
Initial unsolicited report received from a health-care professional on 18-Oct-2017. This case involves 39-year-old female patient, who was vaccinated with 0.5 ml dose of FLUZONE QUADRIVALENT once lot number: UT5937KA (expiry date were unknown) via intramuscular route in the left deltoid on 20-Sep-2017. Patient medical history and concomitant medication were not reported. On an unknown date, after the vaccination, patient experienced tingling sensation in her fingers off/on and symptoms of limited ROM and use of the left arm. Lab data and corrective treatment were not reported. Event outcome was unknown at the time of reporting. List of documents held by sender: none. Follow up report received from a health-care professional on 02-Jan-2018. No new information's received. List of documents held by sender: none.
I also get very ill; Initial information received on 03-Dec-2020 regarding an unsolicited valid non-serious social media case received from a consumer (patient).  This case a patient of unknown demographics who get very ill (Illness), while he/she received INFLUENZA VACCINE.  The patient's medical history, medical treatments, vaccinations, family history and concurrent condition were not provided.  Concomitant medication was not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route on unknown site of administration for prophylactic vaccination.  On an unknown date, the patient reported that get very ill (Illness), (non-serious) (unknown latency) following the administration of INFLUENZA VACCINE.  No relevant laboratory data was reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as unknown for illness, at the time of reporting.  There will be no information available on the batch number for this case.
PATIENT REPORTED FEELING TINGLING/TIGHTNESS TO THE BACK OF THROAT.  BP 146/86 HR 88, BENADRYL 50 MG PO GIVEN AT 11:30 AM.
First Dose: Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Apr2021 (Lot number: EWO153) at the age of 65 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (ongoing), notes: Verbatim: Asthma, States it started a long time ago, maybe around 2006-2007; "Virus" (unspecified if ongoing), notes: Caller states she had a virus 3.5-4 years ago. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 09Apr2021, outcome "recovered" (10Apr2021), described as "First Dose: Tiredness".  Additional information: Caller stated she had a virus 3.5-4 years ago. Stated something in an ER made her sick after she left the ER.The only reason she went was she thought she was having a heart attack. Stated that ER was not a clean ER. Caller stated something was around there lingering wherever they took her to check her. When she left there she was deathly ill for a week. Caller stated she needs her glasses to read the vaccine card. AE did not require a visit to Emergency Room or Physician Office. No vaccination was given within 4 weeks of Dose 1. AE(s) following prior vaccinations: None. No relevant tests were done.   No follow-up attempts are possible. No further information is expected.